Short answer
DiaMedica Therapeutics Inc. (DMAC) filed an 8-K current report with the SEC on August 10, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q2 2026 financial results announced for quarter ended June 30, 2026.
DiaMedica Therapeutics Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 financial results announced for quarter ended June 30, 2026
- Detailed results available in Exhibit 99.1 press release
- Earnings disclosure provides investors the company’s latest operating and financial update
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other DiaMedica Therapeutics Inc. 8-K filings
Get the next DMAC 8-K as it lands
Follow DMAC for push alerts, or ask the research agent what this filing means.